Mallinckrodt buying Questcor Pharmaceuticals for about $5.2 billion | iNFOnews | Thompson-Okanagan's News Source

Would you like to subscribe to our newsletter?

Current Conditions Partly Cloudy  20.6°C

Mallinckrodt buying Questcor Pharmaceuticals for about $5.2 billion

ANAHEIM, Calif. - Ireland's Mallinckrodt is buying Questcor Pharmaceuticals Inc. in a deal valued at about $5.2 billion that will help to diversify its business.

Questcor stockholders will receive $30.00 per share in cash and 0.897 Mallinckrodt shares for each Questcor share they own, for a total consideration of approximately $86.10 per Questcor share. Questcor is based in California.

The companies put the transaction's total value at about $5.6 billion.

After the deal closes, Mallinckrodt PLC shareholders will own about 50.5 per cent and former Questcor shareholders will own about 49.5 per cent of the combined company's stock. Both companies' boards unanimously approved the transaction.

The combined company will be headed by Mallinckrodt President and CEO Mark Trudeau. Mallinckrodt's board will expand by three members to 12 directors.

Questcor's stock rose slightly in Monday premarket trading.

News from © The Associated Press, 2014
The Associated Press

  • Popular kamloops News
View Site in: Desktop | Mobile